Deliver Your News to the World

CybeRelease: (OTC: TEDG) Board Has Approved for Its New Name as China Biopharma Inc.


(CybeRelease, July 6, 2006) - Lake Harmony, PA - Techedge Inc. (OTCBB:TEDG) announced that its board of directors has unanimously approved to change its name to the new name as China Biopharma Inc.

“We have finally transitioned our old business operation to the biopharmaceutical business operation in China. It is a right time to change our name. This proposed new name would be more accurately reflect our current business operation, as we are a leading developer, producer and distributor of vaccine products in China. We are ready to distribute flu vaccines as the flu season in China is fast approaching” Peter Wang, CEO of Techedge Inc. stated.

About Techedge, Inc.

Techedge, Inc. is a fast growing developer, producer, and distributor of biopharmaceutical products in China. It has wholly owned subsidiary, China Biopharma Limited and owns the majority interest of Zhejiang Tianyuan Biotech Co., Ltd (“ZTB”). The Company’s current products consist of human vaccines against influenza, epidemic hemorrhagic fever (HFV), and Japanese Encephalitis (JEV) with high reputation and market shares among Chinese made vaccines. Through its investment and ownership of leading Chinese biopharmaceutical companies, the company plans to build the most efficient and most profitable biopharmaceutical company in China by introducing the most advanced technology, best product, and experienced management team. With a fast growing market, newly completed production facility, and several other new vaccines in the pipeline, it is expected to have a steady business growth.

To read the complete release, go to

CybeRelease Gainers are Sigmatel, Inc. (Nasdaq: SGTL), Dyax Corp. (Nasdaq: DYAX), MedCath Corporation (Nasdaq: MDTH), FX Energy, Inc. (Nasdaq: FXEN), Staktek Holdings, Inc. (Nasdaq: STAK), Perma-Fix Environmental Services, Inc. (Nasdaq: PESI), NGAS Resources, Inc. (Nasdaq: NGAS) and Hoku Scientific, Inc. (Nasdaq: HOKU).

CybeRelease Decliners are Emageon Inc. (Nasdaq: EMAG), Phase Forward Incorporated (Nasdaq: PFWD), Net 1 UEPS Technologies, Inc. (Nasdaq: UEPS), ANADIGICS, Inc. (Nasdaq: ANAD), Opsware, Inc. (Nasdaq: OPSW), Wilsons The Leather Experts Inc. (Nasdaq: WLSN), Wheeling-Pittsburgh Corporation (Nasdaq: WPSC) and SpatiaLight, Inc. (Nasdaq: HDTV).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.